Providing Patented Cannabis Extraction Processing Services
This profile is part of a paid investor education campaign.*
Nextleaf Solutions Ltd. (CSE:OILS, OTCQB:OILFF, Frankfurt:L0MA) is an extraction technology company that has developed a portfolio of issued and pending patents pertaining to the company’s unique, industrial-scale process of producing purified cannabinoid distillate, a tasteless, odourless cannabis concentrate best suited for infusing premium value-added products.
The company has been aggressively pursuing IP and have received Canada’s first cannabis processing patent. An additional patent is scheduled to issue in early 2019, and 3 more patents pending. Patent protection has been filed for in 7 countries.
Nextleaf plans to commercialize its intellectual property portfolio by providing B2B processing services to licensed cultivators and supplying cannabis oil and extracts to qualified Canadian and international partners under the client’s own brands.
Nextleaf has completed construction of its 6,540-square-foot dedicated extraction and processing facility in Greater Vancouver, British Columbia, in time for Canada’s legalization of edibles and other cannabis derivative products. The Company’s processing facility includes research and laboratory infrastructure, allowing for the continued development of novel, scalable cannabis processing technology and intellectual property.
In addition, the Company has designed and built a fully-capable mobile extraction lab, which operates under a client’s license, providing extraction services at their location
Nextleaf has assembled a team of engineers and scientists – some of the brightest minds in the industry – to scale up Nextleaf’s extraction and purification technology and capitalize on this once in a generation market opportunity.
The management team has decades of experience in the cannabis industry. The company’s co-founder and CEO Paul Pedersen having previously advised and worked for a number of investors and cannabis companies, including Ample Organics, Lift & Co, and Peace Naturals – the first non-incumbent company to be granted a medical cannabis production license by Health Canada.
- Science and innovation focused company with patented technology
- Nextleaf’s patented processes will impact how edibles, beverages and other value-added products are manufactured, once legalized in Canada and other international markets.
- Technology to process abundant supply of low-quality cannabis biomass into high-purity oil. Odorless and tasteless distillate, easy to standardize for potency.
- Opportunity for early market leadership in high-margin infused product manufacturing
- Scalable white label production and toll processing solutions increase speed to market for Nextleaf B2B partners.
Cannabis Extractions Market
The CBD extracts market is expected to reach $2.1 billion by 2020. Extracts make up the fastest growing segment in the cannabis market in Canada and the US. In the US, dried cannabis flower consumption is declining in California, Colorado and Oregon. In Colorado, dried flower sales dropped from 67 percent of total dispensary sales in 2014 to 44 percent in 2018, while concentrate sales have doubled to 31 percent, according to recent reports from BDS Analytics. Similar patterns are evident in other legal US states.
In Canada, the market for extracts is relatively small as many of the products made with cannabis distillates and extracts have yet to be approved by Health Canada. This is expected to change in October 2019, when Health Canada will release its decision regarding cannabis edibles.
Nextleaf acquired market-validated intellectual property in January 2017, which it developed into a portfolio of issued and pending patents. These pertain to methods, systems and equipment for improving the purity and yield of cannabinoids through extraction and purification of cannabis biomass.
The company’s unique, industrial-scale process of producing purified THC and CBD distillate – a tasteless, odourless cannabis concentrate – is best suited for infusing premium value-added products.
- Topicals and Skincare
- Transdermal Application
- Sublingual Delivery
- Vape technology and specialty extracts
- Edible oils
- Beverages and water-soluble extracts
Nextleaf Solutions is aggressively growing its IP portfolio. To date, the company has secured Canada’s first cannabis processing patent and has filed an additional 19 patents. Patent protection has been applied for in seven countries: the US, Canada, Mexico, Colombia, Jamaica, Europe and Australia.
Patented Extraction Process
The flavours and aromas of cannabis are undesirable in edible and infused products made with crude extracts due to the presence of chlorophyll, fats, lipids and other impurities. Further, consumer preference is shifting towards value-added and derivative products made from cannabis extracts. These require sophisticated processing solutions in order to produce standardized and impurity-free extracts that are easy to dose and formulate.
Nextleaf’s patented process uses a combination of extraction, refinement and purification to create a premium distillate (think: top shelf distilled spirits, like vodka, versus moonshine).
Toll Processing & White Label Manufacturing:
- Scalable extraction services for cultivators looking to maximize the value of their harvest, and who would prefer to outsource the expertise and technology required to produce a premium end product.
IP & Formulation Development:
- Nextleaf develops proprietary formulations for infused products with THC and CBD extracts, significantly increasing speed-to-market for Nextleaf’s B2B partners.
Paul Pedersen, MBA — Co-Founder and CEO
With over 12 years of experience in starting and financing emerging growth companies, Pedersen holds an MBA in Finance from Michigan State University. His first company was acquired in 2007 by Towerstream (NASDAQ: TWER). Pedersen has been deeply involved in the cannabis industry since 2013, having previously advised and worked for a number of investors and cannabis companies, including Ample Organics, Lift & Co, and Peace Naturals – the first non-incumbent company to be granted a medical cannabis production license by Health Canada. After Cronos Group closed its acquisition of Peace Naturals in 2016, Paul Pedersen exited and co-founded Nextleaf Solutions with the vision of setting the global standard for the development of cannabis extraction and purification technology.
Tom Ulanowski — President of Nextleaf Labs
Tom Ulanowski is a Chartered Chemist (ACPO) and holds an H.B.Sc Degree in Analytical Chemistry and Environmental Monitoring from the University of Toronto, as well as an MSc degree in Biogeochemistry from the University of Western Ontario. Ulanowski is the former Quality Assurance Manager, Quality Assurance Person (QAP), and Qualified Person in Charge (QPIC) at Canna Farms Ltd., award-winning craft cannabis. While there he provided quality-assurance for hundreds of batches of cannabis, while helping the company to obtain multiple productions and sales licenses, expand operations, win national industry awards, and increase output ten-fold via expansions, improvements to current practices and the development of new processes and products. In 2018, Tom led the effort to manufacture, license, and market “Canna Kief”, making Canna Farms the first Licensed Producer in Canada to sell a concentrated form of cannabis.
Krupal Pal, Ph.D., P.Eng — Lead Processing Engineer
As a process engineer since 2005, Dr. Krupal Pal has applied fundamental chemical engineering and scientific principles to problems in diverse fields, including extraction technology for oilsands operations, biodiesel processing and the petrochemical industry. Before joining Nextleaf in December 2017, she focused her career on process scale-up and development in industrial research and development.
*Disclaimer: This profile is sponsored by Nextleaf Solutions (CSE:OILS). This company profile provides information which was sourced by the Investing News Network (INN) and approved by Nextleaf Solutions, in order to help investors learn more about the company. Nextleaf Solutions is a client of INN. The company’s campaign fees pay for INN to create and update this profile.
INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.
The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Nextleaf Solutions and seek advice from a qualified investment advisor.